{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:21:44Z","timestamp":1721262104963},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,17]]},"DOI":"10.7759\/cureus.64723","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T11:07:31Z","timestamp":1721214451000},"source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous Hydropneumothorax After Pleurodesis in a Patient With Pulmonary Lymphangioleiomyomatosis With Associated Endometrial Cancer"],"prefix":"10.7759","author":[{"given":"Sabastain F","family":"Forsah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauvain","family":"Kankeu Tonpouwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Ugwendum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvel","family":"Changoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divine Besong","family":"Arrey Agbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibi S","family":"Razak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Muego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1395","article-title":"Minireview: lymphangioleiomyomatosis (LAM): the \"other\" steroid-sensitive cancer","volume":"157","author":"Prizant H","year":"2016","unstructured":"Prizant H, Hammes SR. Minireview: lymphangioleiomyomatosis (LAM): the \"other\" steroid-sensitive cancer. Endocrinology. 2016, 157:3374-83. 10.1210\/en.2016-1395","journal-title":"Endocrinology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2021.03.004","article-title":"Asymptomatic lymphangioleiomyomatosis: large cyst mimicking a hydropneumothorax in a healthy patient","volume":"16","author":"Benedetto C","year":"2021","unstructured":"Benedetto C, Barbaro U, Anfuso C, Militi A, Morabito R, Ruvolo C, Monaco F. Asymptomatic lymphangioleiomyomatosis: large cyst mimicking a hydropneumothorax in a healthy patient. Radiol Case Rep. 2021, 16:1325-8. 10.1016\/j.radcr.2021.03.004","journal-title":"Radiol Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivv022","article-title":"Risk factors for postoperative recurrence of spontaneous pneumothorax treated by video-assisted thoracoscopic surgery","volume":"20","author":"Imperatori A","year":"2015","unstructured":"Imperatori A, Rotolo N, Spagnoletti M, et al.. Risk factors for postoperative recurrence of spontaneous pneumothorax treated by video-assisted thoracoscopic surgery. Interact Cardiovasc Thorac Surg. 2015, 20:647-51. 10.1093\/icvts\/ivv022","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_60_17","article-title":"Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - a case report","volume":"35","author":"Verma AK","year":"2018","unstructured":"Verma AK, Joshi A, Mishra AR, Kant S, Singh A. Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - a case report. Lung India. 2018, 35:154-6. 10.4103\/lungindia.lungindia_60_17","journal-title":"Lung India"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2413-z","article-title":"A case of lymphangioleiomyomatosis associated with endometrial cancer and severe systemic lupus erythematosus","volume":"16","author":"Suzuki K","year":"2016","unstructured":"Suzuki K, Nagasaka K, Oda K, et al.. A case of lymphangioleiomyomatosis associated with endometrial cancer and severe systemic lupus erythematosus. BMC Cancer. 2016, 16:390. 10.1186\/s12885-016-2413-z","journal-title":"BMC Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.917628","article-title":"Pelvic lymph node lymphangiomyomatosis found during surgery for gynecological fallopian tube cancer: a case report and literature review","volume":"9","author":"Xiao S","year":"2022","unstructured":"Xiao S, Chen Y, Tang Q, Xu L, Zhao L, Wang Z, Yu E. Pelvic lymph node lymphangiomyomatosis found during surgery for gynecological fallopian tube cancer: a case report and literature review. Front Med (Lausanne). 2022, 9:917628. 10.3389\/fmed.2022.917628","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcr116","article-title":"Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis","volume":"104","author":"Harknett EC","year":"2011","unstructured":"Harknett EC, Chang WY, Byrnes S, et al.. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011, 104:971-9. 10.1093\/qjmed\/hcr116","journal-title":"QJM"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo T","year":"2000","unstructured":"Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000, 97:6085-90. 10.1073\/pnas.97.11.6085","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","article-title":"Lymphangioleiomyomatosis: clinical aspects","author":"Kalassian KG","year":"1999","unstructured":"Kalassian KG, Berry GJ, Raffin TA. Lymphangioleiomyomatosis: clinical aspects. LAM and Other Diseases Characterized by Smooth Muscle Proliferation. Moss J (ed): Marcel Dekker, New York, NY; 1999. 45-60."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0662","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer","volume":"18","author":"Slomovitz BM","year":"2012","unstructured":"Slomovitz BM, Coleman RL. The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res. 2012, 18:5856-64. 10.1158\/1078-0432.CCR-12-0662","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2009.0020","article-title":"mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \"perfect storm\" of pro-metastatic factors in LAM pathogenesis","volume":"8","author":"Yu J","year":"2010","unstructured":"Yu J, Henske EP. mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \"perfect storm\" of pro-metastatic factors in LAM pathogenesis. Lymphat Res Biol. 2010, 8:43-9. 10.1089\/lrb.2009.0020","journal-title":"Lymphat Res Biol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00025314","article-title":"Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases","volume":"43","author":"Cottin V","year":"2014","unstructured":"Cottin V. Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases. Eur Respir J. 2014, 43:966-9. 10.1183\/09031936.00025314","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu JH","year":"2006","unstructured":"Ryu JH, Moss J, Beck GJ, et al.. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med. 2006, 173:105-11. 10.1164\/rccm.200409-1298OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","article-title":"Lymphangioleiomyomatosis","author":"Khaddour K","year":"2024","unstructured":"Khaddour K, Sankari A, Shayuk M. Lymphangioleiomyomatosis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack FX","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR, et al.. Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016, 194:748-61. 10.1164\/rccm.201607-1384ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12628-1","article-title":"Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation","volume":"10","author":"Esfahani K","year":"2019","unstructured":"Esfahani K, Al-Aubodah TA, Thebault P, et al.. Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation. Nat Commun. 2019, 10:4712. 10.1038\/s41467-019-12628-1","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.793831","article-title":"Improvement of PD-1 blockade efficacy and elimination of immune-related gastrointestinal adverse effect by mTOR inhibitor","volume":"12","author":"Bai X","year":"2021","unstructured":"Bai X, Wang X, Ma G, et al.. Improvement of PD-1 blockade efficacy and elimination of immune-related gastrointestinal adverse effect by mTOR inhibitor. Front Immunol. 2021, 12:793831. 10.3389\/fimmu.2021.793831","journal-title":"Front Immunol"},{"key":"ref18","article-title":"Pleurodesis","author":"Ali M","year":"2024","unstructured":"Ali M, Surani S. Pleurodesis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-3257","article-title":"Recurrence of primary spontaneous pneumothorax following bullectomy with pleurodesis or pleurectomy: a retrospective analysis","volume":"13","author":"Brophy S","year":"2021","unstructured":"Brophy S, Brennan K, French D. Recurrence of primary spontaneous pneumothorax following bullectomy with pleurodesis or pleurectomy: a retrospective analysis. J Thorac Dis. 2021, 13:1603-11. 10.21037\/jtd-20-3257","journal-title":"J Thorac Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275073-spontaneous-hydropneumothorax-after-pleurodesis-in-a-patient-with-pulmonary-lymphangioleiomyomatosis-with-associated-endometrial-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T11:07:36Z","timestamp":1721214456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275073-spontaneous-hydropneumothorax-after-pleurodesis-in-a-patient-with-pulmonary-lymphangioleiomyomatosis-with-associated-endometrial-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.64723","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}